Journal Article
V. Busby, Goossens, S., Nowotny, P., Hamilton, G., Smemo, S., Harold, D., Turic, D., Jehu, L., Myers, A., Womick, M., Woo, D., Compton, D., Doil, L. M., Tacey, K. M., Lau, K. F., Al-Saraj, S., Killick, R., Pickering-Brown, S., Moore, P., Hollingworth, P., Archer, N., Foy, C., Walter, S., Lendon, C., Iwatsubo, T., Morris, J. C., Norton, J., Mann, D., Janssens, B., Hardy, J., O'Donovan, M., Jones, L., Williams, J., Holmans, P., Owen, M. J., Grupe, A., Powell, J., van Hengel, J., Goate, A., Van Roy, F., and Lovestone, S.,
“Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease.”,
Neuromolecular Med, vol. 5, no. 2, pp. 133-46, 2004.
P. G. Ridge, Mukherjee, S., Crane, P. K., and Kauwe, J. S. K.,
“Alzheimer's disease: analyzing the missing heritability.”,
PLoS One, vol. 8, no. 11, p. e79771, 2013.
C. M. Karch, Cruchaga, C., and Goate, A. M.,
“Alzheimer's disease genetics: from the bench to the clinic.”,
Neuron, vol. 83, no. 1, pp. 11-26, 2014.
C. M. Karch, Ezerskiy, L. A., Bertelsen, S., and Goate, A. M.,
“Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.”,
PLoS One, vol. 11, no. 2, p. e0148717, 2016.
J. H. Lee, Cheng, R., Graff-Radford, N., Foroud, T., and Mayeux, R.,
“Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci.”,
Arch Neurol, vol. 65, no. 11, pp. 1518-26, 2008.
S. Swaminathan, Huentelman, M. J., Corneveaux, J. J., Myers, A. J., Faber, K. M., Foroud, T., Mayeux, R., Shen, L., Kim, S., Turk, M., Hardy, J., Reiman, E. M., and Saykin, A. J.,
“Analysis of copy number variation in Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.”,
PLoS One, vol. 7, no. 12, p. e50640, 2012.
M. Victoria Fernández, Kim, J. Hun, Budde, J. P., Black, K., Medvedeva, A., Saef, B., Deming, Y., Del-Aguila, J., Ibañez, L., Dube, U., Harari, O., Norton, J., Chasse, R., Morris, J. C., Goate, A., and Cruchaga, C.,
“Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.”,
PLoS Genet, vol. 13, no. 11, p. e1007045, 2017.
D. Mastroeni, Sekar, S., Nolz, J., Delvaux, E., Lunnon, K., Mill, J., Liang, W. S., and Coleman, P. D.,
“ANK1 is up-regulated in laser captured microglia in Alzheimer's brain; the importance of addressing cellular heterogeneity.”,
PLoS One, vol. 12, no. 7, p. e0177814, 2017.
W. A. Kukull, Schellenberg, G. D., Bowen, J. D., McCormick, W. C., Yu, C. E., Teri, L., Thompson, J. D., O'Meara, E. S., and Larson, E. B.,
“Apolipoprotein E in Alzheimer's disease risk and case detection: a case-control study.”,
J Clin Epidemiol, vol. 49, no. 10, pp. 1143-8, 1996.
M. Ghani, Reitz, C., Cheng, R., Vardarajan, B. Narayan, Jun, G., Sato, C., Naj, A., Rajbhandary, R., San Wang, L. -, Valladares, O., Lin, C. - F., Larson, E. B., Graff-Radford, N. R., Evans, D., De Jager, P. L., Crane, P. K., Buxbaum, J. D., Murrell, J. R., Raj, T., Ertekin-Taner, N., Logue, M., Baldwin, C. T., Green, R. C., Barnes, L. L., Cantwell, L. B., M Fallin, D., Go, R. C. P., Griffith, P. A., Obisesan, T. O., Manly, J. J., Lunetta, K. L., M Kamboh, I., Lopez, O. L., Bennett, D. A., Hendrie, H., Hall, K. S., Goate, A. M., Byrd, G. S., Kukull, W. A., Foroud, T. M., Haines, J. L., Farrer, L. A., Pericak-Vance, M. A., Lee, J. H., Schellenberg, G. D., St George-Hyslop, P., Mayeux, R., and Rogaeva, E.,
“Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals.”,
JAMA Neurol, vol. 72, no. 11, pp. 1313-23, 2015.
P. Nowotny, Hinrichs, A. L., Smemo, S., Kauwe, J. S. K., Maxwell, T., Holmans, P., Hamshere, M., Turic, D., Jehu, L., Hollingworth, P., Moore, P., Bryden, L., Myers, A., Doil, L. M., Tacey, K. M., Gibson, A. M., McKeith, I. G., Perry, R. H., Morris, C. M., Thal, L., Morris, J. C., O'Donovan, M. C., Lovestone, S., Grupe, A., Hardy, J., Owen, M. J., Williams, J., and Goate, A.,
“Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme.”,
Am J Med Genet B Neuropsychiatr Genet, vol. 136B, no. 1, pp. 62-8, 2005.
P. Hollingworth, Harold, D., Sims, R., Gerrish, A., Lambert, J. - C., Carrasquillo, M. M., Abraham, R., Hamshere, M. L., Pahwa, J. Singh, Moskvina, V., Dowzell, K., Jones, N., Stretton, A., Thomas, C., Richards, A., Ivanov, D., Widdowson, C., Chapman, J., Lovestone, S., Powell, J., Proitsi, P., Lupton, M. K., Brayne, C., Rubinsztein, D. C., Gill, M., Lawlor, B., Lynch, A., Brown, K. S., Passmore, P. A., Craig, D., McGuinness, B., Todd, S., Holmes, C., Mann, D., A Smith, D., Beaumont, H., Warden, D., Wilcock, G., Love, S., Kehoe, P. G., Hooper, N. M., Vardy, E. R. L. C., Hardy, J., Mead, S., Fox, N. C., Rossor, M., Collinge, J., Maier, W., Jessen, F., Rüther, E., Schürmann, B., Heun, R., Kölsch, H., van den Bussche, H., Heuser, I., Kornhuber, J., Wiltfang, J., Dichgans, M., Frölich, L., Hampel, H., Gallacher, J., Hüll, M., Rujescu, D., Giegling, I., Goate, A. M., Kauwe, J. S. K., Cruchaga, C., Nowotny, P., Morris, J. C., Mayo, K., Sleegers, K., Bettens, K., Engelborghs, S., De Deyn, P. P., Van Broeckhoven, C., Livingston, G., Bass, N. J., Gurling, H., McQuillin, A., Gwilliam, R., Deloukas, P., Al-Chalabi, A., Shaw, C. E., Tsolaki, M., Singleton, A. B., Guerreiro, R., Mühleisen, T. W., Nöthen, M. M., Moebus, S., Jöckel, K. - H., Klopp, N., Wichmann, H. - E., V Pankratz, S., Sando, S. B., Aasly, J. O., Barcikowska, M., Wszolek, Z. K., Dickson, D. W., Graff-Radford, N. R., Petersen, R. C., van Duijn, C. M., Breteler, M. M. B., M Ikram, A., DeStefano, A. L., Fitzpatrick, A. L., Lopez, O., Launer, L. J., Seshadri, S., Berr, C., Campion, D., Epelbaum, J., Dartigues, J. - F., Tzourio, C., Alpérovitch, A., Lathrop, M., Feulner, T. M., Friedrich, P., Riehle, C., Krawczak, M., Schreiber, S., Mayhaus, M., Nicolhaus, S., Wagenpfeil, S., Steinberg, S., Stefansson, H., Stefansson, K., Snaedal, J., Björnsson, S., Jonsson, P. V., Chouraki, V., Genier-Boley, B., Hiltunen, M., Soininen, H., Combarros, O., Zelenika, D., Delepine, M., Bullido, M. J., Pasquier, F., Mateo, I., Frank-Garcia, A., Porcellini, E., Hanon, O., Coto, E., Alvarez, V., Bosco, P., Siciliano, G., Mancuso, M., Panza, F., Solfrizzi, V., Nacmias, B., Sorbi, S., Bossù, P., Piccardi, P., Arosio, B., Annoni, G., Seripa, D., Pilotto, A., Scarpini, E., Galimberti, D., Brice, A., Hannequin, D., Licastro, F., Jones, L., Holmans, P. A., Jonsson, T., Riemenschneider, M., Morgan, K., Younkin, S. G., Owen, M. J., O'Donovan, M., Amouyel, P., and Williams, J.,
“Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.”,
Nat Genet, vol. 43, no. 5, pp. 429-35, 2011.
K. K. Nicodemus, Stenger, J. E., Schmechel, D. E., Welsh-Bohmer, K. A., Saunders, A. M., Roses, A. D., Gilbert, J. R., Vance, J. M., Haines, J. L., Pericak-Vance, M. A., and Martin, E. R.,
“Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.”,
Neurogenetics, vol. 5, no. 4, pp. 201-8, 2004.
M. W. Logue, Schu, M., Vardarajan, B. N., Buros, J., Green, R. C., Go, R. C. P., Griffith, P., Obisesan, T. O., Shatz, R., Borenstein, A., L Cupples, A., Lunetta, K. L., M Fallin, D., Baldwin, C. T., and Farrer, L. A.,
“A comprehensive genetic association study of Alzheimer disease in African Americans.”,
Arch Neurol, vol. 68, no. 12, pp. 1569-79, 2011.
M. Saleh, Vaillancourt, J. P., Graham, R. K., Huyck, M., Srinivasula, S. M., Alnemri, E. S., Steinberg, M. H., Nolan, V., Baldwin, C. T., Hotchkiss, R. S., Buchman, T. G., Zehnbauer, B. A., Hayden, M. R., Farrer, L. A., Roy, S., and Nicholson, D. W.,
“Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms.”,
Nature, vol. 429, no. 6987, pp. 75-9, 2004.
N. Ertekin-Taner, Ronald, J., Feuk, L., Prince, J., Tucker, M., Younkin, L., Hella, M., Jain, S., Hackett, A., Scanlin, L., Kelly, J., Kihiko-Ehman, M., Neltner, M., Hersh, L., Kindy, M., Markesbery, W., Hutton, M., de Andrade, M., Petersen, R. C., Graff-Radford, N., Estus, S., Brookes, A. J., and Younkin, S. G.,
“Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.”,
Hum Mol Genet, vol. 14, no. 3, pp. 447-60, 2005.
J. H. Lee, Cheng, R., Rogaeva, E., Meng, Y., Stern, Y., Santana, V., Lantigua, R., Medrano, M., Jimenez-Velazquez, I. Z., Farrer, L. A., St George-Hyslop, P., and Mayeux, R.,
“Further examination of the candidate genes in chromosome 12p13 locus for late-onset Alzheimer disease.”,
Neurogenetics, vol. 9, no. 2, pp. 127-38, 2008.
R. K. Gopalraj, Zhu, H., Kelly, J. F., Mendiondo, M., Pulliam, J. F., Bennett, D. A., and Estus, S.,
“Genetic association of low density lipoprotein receptor and Alzheimer's disease.”,
Neurobiol Aging, vol. 26, no. 1, pp. 1-7, 2005.
J. A. Webster, J Gibbs, R., Clarke, J., Ray, M., Zhang, W., Holmans, P., Rohrer, K., Zhao, A., Marlowe, L., Kaleem, M., McCorquodale, D. S., Cuello, C., Leung, D., Bryden, L., Nath, P., Zismann, V. L., Joshipura, K., Huentelman, M. J., Hu-Lince, D., Coon, K. D., Craig, D. W., Pearson, J. V., Heward, C. B., Reiman, E. M., Stephan, D., Hardy, J., and Myers, A. J.,
“Genetic control of human brain transcript expression in Alzheimer disease.”,
Am J Hum Genet, vol. 84, no. 4, pp. 445-58, 2009.
E. E. Blue, Bis, J. C., Dorschner, M. O., Tsuang, D. W., Barral, S. M., Beecham, G., Below, J. E., Bush, W. S., Butkiewicz, M., Cruchaga, C., DeStefano, A., Farrer, L. A., Goate, A., Haines, J., Jaworski, J., Jun, G., Kunkle, B., Kuzma, A., Lee, J. J., Lunetta, K. L., Ma, Y., Martin, E., Naj, A., Nato, A. Q., Navas, P., Nguyen, H., Reitz, C., Reyes, D., Salerno, W., Schellenberg, G. D., Seshadri, S., Sohi, H., Thornton, T. A., Valadares, O., van Duijn, C., Vardarajan, B. N., San Wang, L. -, Boerwinkle, E., Dupuis, J., Pericak-Vance, M. A., Mayeux, R., and Wijsman, E. M.,
“Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project.”,
Dement Geriatr Cogn Disord, vol. 45, no. 1-2, pp. 1-17, 2018.
M. M. Carrasquillo, Zou, F., V Pankratz, S., Wilcox, S. L., Ma, L., Walker, L. P., Younkin, S. G., Younkin, C. S., Younkin, L. H., Bisceglio, G. D., Ertekin-Taner, N., Crook, J. E., Dickson, D. W., Petersen, R. C., Graff-Radford, N. R., and Younkin, S. G.,
“Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease.”,
Nat Genet, vol. 41, no. 2, pp. 192-8, 2009.
L. Bertram, Lange, C., Mullin, K., Parkinson, M., Hsiao, M., Hogan, M. F., Schjeide, B. M. M., Hooli, B., Divito, J., Ionita, I., Jiang, H., Laird, N., Moscarillo, T., Ohlsen, K. L., Elliott, K., Wang, X., Hu-Lince, D., Ryder, M., Murphy, A., Wagner, S. L., Blacker, D., K Becker, D., and Tanzi, R. E.,
“Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.”,
Am J Hum Genet, vol. 83, no. 5, pp. 623-32, 2008.
G. W. Beecham, Hamilton, K., Naj, A. C., Martin, E. R., Huentelman, M., Myers, A. J., Corneveaux, J. J., Hardy, J., Vonsattel, J. - P., Younkin, S. G., Bennett, D. A., De Jager, P. L., Larson, E. B., Crane, P. K., M Kamboh, I., Kofler, J. K., Mash, D. C., Duque, L., Gilbert, J. R., Gwirtsman, H., Buxbaum, J. D., Kramer, P., Dickson, D. W., Farrer, L. A., Frosch, M. P., Ghetti, B., Haines, J. L., Hyman, B. T., Kukull, W. A., Mayeux, R. P., Pericak-Vance, M. A., Schneider, J. A., Trojanowski, J. Q., Reiman, E. M., Schellenberg, G. D., and Montine, T. J.,
“Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.”,
PLoS Genet, vol. 10, no. 9, p. e1004606, 2014.
C. Cruchaga, Kauwe, J. S. K., Harari, O., Jin, S. Chih, Cai, Y., Karch, C. M., Benitez, B. A., Jeng, A. T., Skorupa, T., Carrell, D., Bertelsen, S., Bailey, M., McKean, D., Shulman, J. M., De Jager, P. L., Chibnik, L., Bennett, D. A., Arnold, S. E., Harold, D., Sims, R., Gerrish, A., Williams, J., Van Deerlin, V. M., Lee, V. M. - Y., Shaw, L. M., Trojanowski, J. Q., Haines, J. L., Mayeux, R., Pericak-Vance, M. A., Farrer, L. A., Schellenberg, G. D., Peskind, E. R., Galasko, D., Fagan, A. M., Holtzman, D. M., Morris, J. C., and Goate, A. M.,
“GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.”,
Neuron, vol. 78, no. 2, pp. 256-68, 2013.
G. U. Höglinger, Melhem, N. M., Dickson, D. W., Sleiman, P. M. A., San Wang, L. -, Klei, L., Rademakers, R., de Silva, R., Litvan, I., Riley, D. E., van Swieten, J. C., Heutink, P., Wszolek, Z. K., Uitti, R. J., Vandrovcova, J., Hurtig, H. I., Gross, R. G., Maetzler, W., Goldwurm, S., Tolosa, E., Borroni, B., Pastor, P., Cantwell, L. B., Han, M. Ryung, Dillman, A., van der Brug, M. P., J Gibbs, R., Cookson, M. R., Hernandez, D. G., Singleton, A. B., Farrer, M. J., Yu, C. - E., Golbe, L. I., Revesz, T., Hardy, J., Lees, A. J., Devlin, B., Hakonarson, H., Müller, U., and Schellenberg, G. D.,
“Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.”,
Nat Genet, vol. 43, no. 7, pp. 699-705, 2011.
] Year